Neurodegenerative Disorders
Neurodegenerative disorders are a group of conditions that involve the gradual degeneration of the nervous system, leading to symptoms such as memory loss, difficulty with movement, and cognitive decline.
Neurodegenerative Disease: Continued Access to Latozinemab
We are offering ongoing access to the medication latozinemab for individuals with neurodegenerative diseases who have participated in earlier studies. The trial will monitor safety and any clinical benefits from continued treatment.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a woman who is not pregnant or breastfeeding?
- Are you a man who agrees not to donate sperm during the study?
- Do you have significant kidney disease?
- Do you have impaired liver function?
- Do you have a known history of severe allergic reactions to certain medications or treatments?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Latozinemab
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Leuven
Neurology
Heverlee, Belgium
Assistance Publique Hopitaux De Paris
Département des maladies du système nerveux
Salpêtrière, France
Universitaetsklinikum Ulm AöR
Department of Neurology, University Hospital Ulm
Klingenstein, Germany
Sponsor: Alector LLC
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.